| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vericel Corp | Director | Common Stock | 28.7K | $107K | $3.74 | Oct 17, 2024 | Direct |
| Vericel Corp | Director | Restricted Stock Unit | 3.2K | $57.6K | $18.00 | May 1, 2024 | Direct |
| ZIOPHARM ONCOLOGY INC | Director | Common Stock | 146K | $20.5K | $0.14 | Sep 2, 2021 | Direct |
| Vericel Corp | Director | Stock Option (Right to Buy) | 9K | Oct 17, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VCEL | Vericel Corp | Oct 17, 2024 | 4 | $37.4K | 4 | Oct 21, 2024 | Director |
| VCEL | Vericel Corp | May 1, 2024 | 4 | $0 | 4 | May 3, 2024 | Director |
| VCEL | Vericel Corp | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
| VCEL | Vericel Corp | Apr 27, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
| VCEL | Vericel Corp | Apr 27, 2022 | 4 | $0 | 4 | Apr 29, 2022 | Director |
| TCRT | ZIOPHARM ONCOLOGY INC | Sep 2, 2021 | 1 | $41.8K | 4 | Sep 3, 2021 | Director |
| VCEL | Vericel Corp | May 19, 2021 | 6 | $34.9K | 4 | May 20, 2021 | Director |